Investigational site

Las Vegas, Nevada 89178

0 studies enrolling now · 13 studies all time

What they study most

Age-related Macular Degeneration, Alzheimer's Disease, Anemia Associated With End Stage Renal Disease, Anemia Associated With End Stage Renal Disease (ESRD), Bipolar Disorder, Dry Eye Disease (DED), Low Back Pain, Nocturia, Pain, Postherpetic Neuralgia, Rabies Virus, Rheumatoid Arthritis

Studies at this site

• Study of Roxadustat Conversion in Participants Receiving Stable Erythropoiesis-Stimulating Agent (ESA) or as Initial Anemia Treatment in Chronic Dialysis Participants — Completed
• Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants — Completed
• Immunogenicity and Safety of a Purified Vero Rabies Vaccine — Completed
• A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD) — Completed
• Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD — Status unconfirmed
• Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder — Completed
• Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
• Phase 3 Study of EBI-005 in Dry Eye Disease — Completed
• A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE) — Completed
• A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain — Completed
• Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN) — Completed
• A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early